Jack Nielsen - 14 Jun 2023 Form 4 Insider Report for Instil Bio, Inc. (TIL)

Reporting relationship: Director
Issuer ticker: TIL
Reported as of: 14 Jun 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 10 Jan 2024, 19:48:01 UTC
Prior SEC filing: 13 Jun 2023
Next SEC filing: 22 Jun 2023
Source filing: View source filing
Reporting owner signature: /s/ Sandeep Laumas, M.D. Attorney-in-Fact for Jack B. Nielsen

Key filing fact

Jack Nielsen filed Form 4 for Instil Bio, Inc. (TIL) on 10 Jan 2024.

Key facts

This page summarizes Jack Nielsen's Form 4 filing for Instil Bio, Inc. (TIL).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 10 Jan 2024, 19:48.

Change

Previous filing in this sequence was filed on 13 Jun 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TIL transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +1,500
Change %
Price: $0.000000
Shares after: 1,500
Date: 14 Jun 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,500
Exercise price: $11.18
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option will vest in 12 equal monthly installments commencing on July 14, 2023, subject to the Report Person's continued service as a director through the vesting date.